Early Life Phthalate and Perfluoroalkyl Substance Exposures and Childhood Bone Health
生命早期邻苯二甲酸盐和全氟烷基物质暴露与儿童骨骼健康
基本信息
- 批准号:10062975
- 负责人:
- 金额:$ 42.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:12 year old25-hydroxyvitamin D8 year oldAddressAdolescenceAdultAffectAgeAmericanAnimalsAwardBayesian AnalysisBayesian ModelingBiologicalBiological MarkersBiometryBirthBody CompositionBone DensityBone DevelopmentBone DiseasesBone GrowthBone ResorptionCalciumChemical ExposureChemicalsChildChild WelfareChildhoodClinicalCohort StudiesCross-Sectional StudiesDataDevelopmentDietary InterventionDual-Energy X-Ray AbsorptiometryEnrollmentEnvironmentEnvironmental EpidemiologyEnvironmental HealthEnvironmental ImpactEpidemiologyExposure toFosteringGoalsGrowthHealthHeightHumanImpairmentIntakeInterventionLaboratory FindingLeadLifeLongitudinal StudiesLongitudinal cohort studyMeasurementMeasuresMediatingMediationMetabolismMicronutrientsMineralsModelingModificationNational Institute of Environmental Health SciencesNatureNutritionalOhioOsteogenesisOsteoporosisOutcome MeasurePediatricsPoly-fluoroalkyl substancesPredispositionPregnancyReportingResearchResearch PersonnelRisk FactorsRoleRotationScientistSerumSkeletal DevelopmentTestingToxic effectToxicant exposureTranslationsVisitVitamin DWorkbonebone healthbone massbone strengthbone turnovercalcium intakecareer developmentchemical associationconsumer productcritical periodearly adolescenceearly childhoodearly life exposureenvironmental chemicalepidemiology studyexposed human populationfollow-upfracture riskinnovationmodifiable riskmulti-ethnicnovelnutritional epidemiologyobesogenphthalatesprenatalprogramsprospectiveracial diversityskeletaltooltoxicanturinary
项目摘要
Abstract
Phthalates and perfluoroalkyl substances (PFAS) are synthetic chemicals with widespread human exposures
that lower bone density in animals. Our preliminary data and limited epidemiologic studies report associations
of these chemicals with shorter stature in children as well as lower bone density and altered vitamin D
metabolism in adults. Low peak bone mass in adolescence is a strong modifiable risk factor for osteoporosis, a
bone disease impacting millions of older Americans. Although early life is a critical period of skeletal growth
and bone mass accrual, there are currently no longitudinal studies of phthalate or PFAS exposures in relation
to childhood bone density. Therefore, our goal is to test the novel hypothesis that early life phthalate and PFAS
exposures adversely impact skeletal growth, bone strength, and vitamin D metabolism in children. Our highly
efficient proposal leverages the Health Outcomes and Measures of the Environment (HOME) Study, a
prospective, racially-diverse pregnancy cohort study enrolled in Cincinnati, Ohio with existing exposure
biomarker, confounder, and height measures from gestation through 8 years of age. Dual-energy X-ray
absorptiometry measurements of bone density are currently being collected at an ongoing 12-year follow-up
visit. We will additionally measure validated vitamin D and phthalate exposure biomarkers to investigate
whether phthalate or PFAS exposures are associated with height trajectories from birth to age 12 years (Aim
1), bone density at age 12 years (Aim 2), and vitamin D biomarker concentrations at ages 8 and 12 years (Aim
3). Further, we will explore the role of chemical and nutritional co-exposures by examining whether height or
bone density associations are modified or mediated by vitamin D biomarker concentrations or calcium intake
(Aim 4). Using rich longitudinal data and a sophisticated Bayesian modeling approach, we will investigate
potential windows of susceptibility (prenatal, early childhood, mid childhood, and early adolescence) as well as
effects of cumulative exposures and exposure mixtures. This research will constitute the first systematic
assessment of the role of phthalates and PFAS in altering bone health, a significant but understudied
component of child well-being with critical importance for life-long risk of fractures and osteoporosis. In
addition, this NIEHS ONES Award will support an exceptional Early Stage Investigator to establish an
innovative research program specializing in children's environmental health. Finally, our findings will catalyze
future research examining environmental impacts on bone health in later adolescence, elucidating biological
mechanisms, investigating other environmental bone toxicants, and developing chemical or nutritional
interventions with the goal of setting children on a path to healthier, stronger bones throughout life.
抽象的
邻苯二甲酸盐和全氟烷基物质 (PFAS) 是人类广泛接触的合成化学品
降低动物的骨密度。我们的初步数据和有限的流行病学研究报告关联
这些化学物质会导致儿童身材矮小、骨密度降低和维生素 D 改变
成人的新陈代谢。青春期的低峰值骨量是骨质疏松症的一个强大的可改变危险因素,
骨病影响着数百万美国老年人。虽然生命早期是骨骼生长的关键时期
和骨量增长,目前尚无邻苯二甲酸盐或 PFAS 暴露与相关性的纵向研究
到儿童时期的骨密度。因此,我们的目标是检验生命早期邻苯二甲酸盐和 PFAS 的新假设
暴露会对儿童骨骼生长、骨强度和维生素 D 代谢产生不利影响。我们的高度
有效的提案利用了健康结果和环境措施(HOME)研究,
在俄亥俄州辛辛那提市招募的前瞻性、种族多样化妊娠队列研究,具有现有暴露情况
从妊娠期到 8 岁的生物标志物、混杂因素和身高测量。双能X射线
目前正在持续 12 年的随访中收集骨密度的吸收测量结果
访问。我们还将额外测量经过验证的维生素 D 和邻苯二甲酸盐暴露生物标志物以进行调查
邻苯二甲酸盐或 PFAS 暴露是否与从出生到 12 岁的身高轨迹相关(Aim
1)、12 岁时的骨密度(目标 2)以及 8 岁和 12 岁时的维生素 D 生物标志物浓度(目标
3)。此外,我们将通过检查身高或体重来探索化学和营养共同暴露的作用。
骨密度关联由维生素 D 生物标志物浓度或钙摄入量改变或介导
(目标 4)。使用丰富的纵向数据和复杂的贝叶斯建模方法,我们将调查
潜在的易感性窗口(产前、儿童早期、儿童中期和青春期早期)以及
累积暴露和暴露混合物的影响。这项研究将构成第一个系统的
评估邻苯二甲酸盐和 PFAS 在改变骨骼健康方面的作用,这是一项重要但尚未充分研究的研究
儿童福祉的组成部分,对于终生骨折和骨质疏松症风险至关重要。在
此外,NIEHS ONES 奖将支持杰出的早期研究人员建立一个
专门研究儿童环境健康的创新研究计划。最后,我们的发现将促进
未来的研究将检验环境对青春期后期骨骼健康的影响,阐明生物
机制,研究其他环境骨毒物,并开发化学或营养
旨在让儿童终生拥有更健康、更强健骨骼的干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessie P Buckley其他文献
Jessie P Buckley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessie P Buckley', 18)}}的其他基金
Early Life Phthalate and Perfluoroalkyl Substance Exposures and Childhood Bone Health
生命早期邻苯二甲酸盐和全氟烷基物质暴露与儿童骨骼健康
- 批准号:
10872041 - 财政年份:2023
- 资助金额:
$ 42.99万 - 项目类别:
Endocrine disrupting chemical mixtures and bone health in adolescence
内分泌干扰化学混合物与青春期骨骼健康
- 批准号:
10278876 - 财政年份:2021
- 资助金额:
$ 42.99万 - 项目类别:
Endocrine disrupting chemical mixtures and bone health in adolescence
内分泌干扰化学混合物与青春期骨骼健康
- 批准号:
10874040 - 财政年份:2021
- 资助金额:
$ 42.99万 - 项目类别:
Early Life Phthalate and Perfluoroalkyl Substance Exposures and Childhood Bone Health
生命早期邻苯二甲酸盐和全氟烷基物质暴露与儿童骨骼健康
- 批准号:
10531865 - 财政年份:2019
- 资助金额:
$ 42.99万 - 项目类别:
Early Life Phthalate and Perfluoroalkyl Substance Exposures and Childhood Bone Health
生命早期邻苯二甲酸盐和全氟烷基物质暴露与儿童骨骼健康
- 批准号:
10302297 - 财政年份:2019
- 资助金额:
$ 42.99万 - 项目类别:
相似国自然基金
一般人群25-羟基维生素D与高血压关系的研究
- 批准号:81102189
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
在中国汉族人群内Gc-rs4588变异对血浆25-羟基维生素D浓度的影响及其潜在机理的研究
- 批准号:81170734
- 批准年份:2011
- 资助金额:70.0 万元
- 项目类别:面上项目
失C环1α,25-二羟基维生素D3类似物的全合成和生物活性研究
- 批准号:29972013
- 批准年份:1999
- 资助金额:12.0 万元
- 项目类别:面上项目
相似海外基金
Contribution of Vitamin D Deficiency to Pathological Progression in Models of Cerebral Hypoperfusion
维生素 D 缺乏对脑低灌注模型病理进展的影响
- 批准号:
10725358 - 财政年份:2023
- 资助金额:
$ 42.99万 - 项目类别:
Plasma 25-Hydroxyvitamin D Concentration and Incident Risk of Dementia: a Case-cohort Study
血浆 25-羟基维生素 D 浓度和痴呆症事件风险:病例队列研究
- 批准号:
23K19881 - 财政年份:2023
- 资助金额:
$ 42.99万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Contraceptive DMPA-induced bone loss: A novel source of toxic metal lead exposure in young women
避孕药 DMPA 引起的骨质流失:年轻女性有毒金属铅暴露的新来源
- 批准号:
10714991 - 财政年份:2023
- 资助金额:
$ 42.99万 - 项目类别:
Early Life Phthalate and Perfluoroalkyl Substance Exposures and Childhood Bone Health
生命早期邻苯二甲酸盐和全氟烷基物质暴露与儿童骨骼健康
- 批准号:
10872041 - 财政年份:2023
- 资助金额:
$ 42.99万 - 项目类别:
Establishing the role of genetic variation in vitamin D-regulated gene expression in Sjogrens disease pathogenesis
确定遗传变异在维生素 D 调节的基因表达中在干燥病发病机制中的作用
- 批准号:
10537064 - 财政年份:2022
- 资助金额:
$ 42.99万 - 项目类别: